Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.

Food and Drug Administration, HHS.

Fed Regist. 2002 May 9;67(90):31125-7.

2.

OTC drugs: categories I, II, and III.

Whitehill D.

S D J Med. 2003 Jun;56(6):221-2. Review. No abstract available.

PMID:
12827937
4.

An overview of over the counter drugs in pregnancy and lactation.

Das BP, Joshi M, Pant CR.

Kathmandu Univ Med J (KUMJ). 2006 Oct-Dec;4(4):545-51. Review.

PMID:
18603972
5.

Drugs and other product choices.

Hyman PM, Carvajal R.

Dermatol Ther. 2009 May-Jun;22(3):216-24. doi: 10.1111/j.1529-8019.2009.01234.x. Review.

PMID:
19453345
6.

Prescription to over-the-counter switch: a regulatory perspective.

Juhl RP.

Clin Ther. 1998;20 Suppl C:C111-7. Review.

PMID:
9915097
7.
8.

Regulatory issues in pediatric psychopharmacology.

Laughren TP.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1276-82. Review.

PMID:
8885581
9.

Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Roumie CL, Griffin MR.

Drugs Aging. 2004;21(8):485-98. Review.

PMID:
15182214
10.

Over-the-counter medications and self-care.

Lowe NK, Ryan-Wenger NM.

Nurse Pract. 1999 Dec;24(12):34-44. Review.

PMID:
10635517
12.

Pediatric research: coming of age in the new millennium.

Milne CP.

Am J Ther. 1999 Sep;6(5):263-82. Review.

PMID:
11329108
13.

What you need to know: over the counter slimming products--their rationality and legality.

Candlish JK.

Singapore Med J. 1999 Aug;40(8):550-2. Review. No abstract available.

PMID:
10572500
14.

Implications of the reclassification of drugs from prescription-only to over-the-counter status.

Gossel TA.

Clin Ther. 1991 Mar-Apr;13(2):200-15; discussion 199. Review.

PMID:
1863936
15.

New OTC drugs: a selected review.

Popovich NG, Newton GD, Pray WS.

Am Pharm. 1992 Feb;NS32(2):26-7, 37-8. Review. No abstract available.

PMID:
1546627
16.

New OTC drugs and devices: a selected review.

Newton GD, Pray WS, Popovich NG.

Am Pharm. 1995 Feb;NS35(2):35-46. Review. No abstract available.

PMID:
7900651
17.

Review article: over-the-counter drugs and the gastrointestinal tract.

Sheen CL, Colin-Jones DG.

Aliment Pharmacol Ther. 2001 Sep;15(9):1263-70. Review.

18.

New OTC drugs and devices 2000: a selective review.

Newton GD, Pray WS, Popovich NG.

J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):273-82. Review.

PMID:
11297337
19.

The Food and Drug Administration's perspective on plasma safety.

Hoots WK, Abrams C, Tankersley D.

Transfus Med Rev. 2001 Apr;15(2 Suppl 1):20-6. Review.

PMID:
11441417
20.

Mandatory nutrition labeling--FDA's final rule.

[No authors listed]

Nutr Rev. 1993 Apr;51(4):101-5. Review. No abstract available.

PMID:
8515886

Supplemental Content

Support Center